Artificial Intelligence
Nervana Systems, a start-up looking to develop artificial intelligence hardware has just raised a considerable investment. The company is developing specialized hardware for machine learning algorithms. |
Nervana Systems, a San Diego-based startup that is focusing on hardware — not software — to boost the performance of artificial intelligence algorithms, just raised $600,000 from investors according to TechCrunch.
The main investors are Ali and Hadi Partovi, Y Combinator’s Sam Altman and Geoff Ralston, Scott Banister and Allen & Co.
"The algorithms exist and they’re getting better, but hardware requires much higher performance than that. It’s already the bottleneck." |
They’re developing specialized hardware for machine learning algorithms, unlike Google-acquired Deep Mind or Vicarious, which focus on software.
“The algorithms exist and they’re getting better,” said Naveen Rao, a computational neuroscientist who co-founded the company. “But hardware requires much higher performance than that. It’s already the bottleneck.”
Related articles |
Rao worked at Sun Microsystems on UltraSparc processors, then went on to work at a number of other companies before he landed at Qualcomm, where he was part of the neuromorphic research group investigating artificial neural computation.
The study of the human brain is informing advanced artificial intelligence algorithms that can manipulate vast sets of data. Rao said that deep learning could be applied to all sorts of problems from Netflix data for recommendations to complex drug interaction models.
Nervana is focusing on building general-purpose central processing units, that will require less data to be be moved back and forth between parallel processors as they are processed.
Liz Gannes at Re/code writes that the real opportunity of Nervana is that by making deep learning more accessible, it will hopefully help researchers and companies make more interesting breakthroughs in artificial intelligence.
SOURCE TechCrunch
By 33rd Square | Embed |
0 comments:
Post a Comment